These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

177 related articles for article (PubMed ID: 15777206)

  • 21. Identification of autoimmune encephalomyelitis-associated common CDR3 sequences by CDR3 spectratyping and subsequent DNA hybridization.
    Jee Y; Matsumoto Y
    J Neuroimmunol; 2002 May; 126(1-2):37-49. PubMed ID: 12020955
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Management of early inflammatory arthritis. Intervention with immunomodulatory agents: T cell vaccination.
    Kingsley G; Panayi GS
    Baillieres Clin Rheumatol; 1992 Jun; 6(2):435-54. PubMed ID: 1525847
    [TBL] [Abstract][Full Text] [Related]  

  • 23. T-cell receptor peptides as immunotherapy for autoimmune disease.
    Gold DP; Shroeder K; Golding A; Brostoff SW; Wilson DB
    Crit Rev Immunol; 1997; 17(5-6):507-10. PubMed ID: 9419437
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Basic aspects of neuroimmunology as they relate to immunotherapeutic targets: present and future prospects.
    Dalakas MC
    Ann Neurol; 1995 May; 37 Suppl 1():S2-13. PubMed ID: 8968213
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Selective immunointervention in autoimmune diseases: lessons from multiple sclerosis.
    Adorini L
    J Chemother; 2001 Jun; 13(3):219-34. PubMed ID: 11450879
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Vaccination with DNA encoding an immunodominant myelin basic protein peptide targeted to Fc of immunoglobulin G suppresses experimental autoimmune encephalomyelitis.
    Lobell A; Weissert R; Storch MK; Svanholm C; de Graaf KL; Lassmann H; Andersson R; Olsson T; Wigzell H
    J Exp Med; 1998 May; 187(9):1543-8. PubMed ID: 9565646
    [TBL] [Abstract][Full Text] [Related]  

  • 27. T cell receptor peptide therapy for autoimmune encephalomyelitis: stronger immunization is necessary for effective vaccination.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Cell Immunol; 1994 Feb; 153(2):468-78. PubMed ID: 8118876
    [TBL] [Abstract][Full Text] [Related]  

  • 28. T cell receptor usage in autoimmune disease.
    Olive C
    Immunol Cell Biol; 1995 Aug; 73(4):297-307. PubMed ID: 7493765
    [TBL] [Abstract][Full Text] [Related]  

  • 29. [TCR peptide vaccination for autoimmune diseases: involvement of T-T interaction between autoimmune T cells presenting TCR peptide and CD4-CD8- regulatory T cells].
    Yamamura T
    Nihon Rinsho; 1997 Jun; 55(6):1519-24. PubMed ID: 9200942
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Successful prevention and treatment of autoimmune encephalomyelitis by short-term administration of anti-T-cell receptor alpha beta antibody.
    Matsumoto Y; Tsuchida M; Hanawa H; Abo T
    Immunology; 1994 Jan; 81(1):1-7. PubMed ID: 7510661
    [TBL] [Abstract][Full Text] [Related]  

  • 31. T cell receptor gene therapy for autoimmune diseases.
    Fujio K; Okamura T; Okamoto A; Yamamoto K
    Ann N Y Acad Sci; 2007 Sep; 1110():222-32. PubMed ID: 17911437
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Autoimmune pathogenesis of multiple sclerosis: role of autoreactive T lymphocytes and new immunotherapeutic strategies.
    Stinissen P; Raus J; Zhang J
    Crit Rev Immunol; 1997; 17(1):33-75. PubMed ID: 9034723
    [TBL] [Abstract][Full Text] [Related]  

  • 33. 17 beta-estradiol inhibits cytokine, chemokine, and chemokine receptor mRNA expression in the central nervous system of female mice with experimental autoimmune encephalomyelitis.
    Matejuk A; Adlard K; Zamora A; Silverman M; Vandenbark AA; Offner H
    J Neurosci Res; 2001 Sep; 65(6):529-42. PubMed ID: 11550221
    [TBL] [Abstract][Full Text] [Related]  

  • 34. [T cell vaccination--induction of anti-idiotypic immune response against TCR and shift of Th1/Th2 balance].
    Kakimoto K; Hara H
    Nihon Rinsho; 1997 Jun; 55(6):1512-8. PubMed ID: 9200941
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Oral tolerance: immunologic mechanisms and treatment of animal and human organ-specific autoimmune diseases by oral administration of autoantigens.
    Weiner HL; Friedman A; Miller A; Khoury SJ; al-Sabbagh A; Santos L; Sayegh M; Nussenblatt RB; Trentham DE; Hafler DA
    Annu Rev Immunol; 1994; 12():809-37. PubMed ID: 8011298
    [TBL] [Abstract][Full Text] [Related]  

  • 36. CDR3 size spectratyping and sequencing of spectratype-derived TCR of spinal cord T cells in autoimmune encephalomyelitis.
    Kim G; Tanuma N; Kojima T; Kohyama K; Suzuki Y; Kawazoe Y; Matsumoto Y
    J Immunol; 1998 Jan; 160(1):509-13. PubMed ID: 9552010
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Expression of chemokine and receptors in Lewis rats with experimental autoimmune anterior uveitis.
    Fang IM; Yang CH; Lin CP; Yang CM; Chen MS
    Exp Eye Res; 2004 Jun; 78(6):1043-55. PubMed ID: 15109911
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Limited heterogeneity of autoantigens and T cells in autoimmune diseases?
    Acha-Orbea H
    Res Immunol; 1991; 142(5-6):487-90. PubMed ID: 1754724
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Immunoregulation of autoimmune disease by vaccination with T cell receptor peptides.
    Brostoff SW; Howell MD
    Ann N Y Acad Sci; 1991 Dec; 636():71-8. PubMed ID: 1793232
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Critical role for monocyte chemoattractant protein-1 and macrophage inflammatory protein-1alpha in induction of experimental autoimmune myocarditis and effective anti-monocyte chemoattractant protein-1 gene therapy.
    Göser S; Ottl R; Brodner A; Dengler TJ; Torzewski J; Egashira K; Rose NR; Katus HA; Kaya Z
    Circulation; 2005 Nov; 112(22):3400-7. PubMed ID: 16316965
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.